Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
AstraZeneca, Cambridge (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Doctor R. Klingenberg (Frankfurt, DE)
Doctor G. Vergaro (Pisa, IT)
Doctor A. Reese-Petersen (Copenhagen, DK)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
